Article
Eptinezumab for the Prevention of Migraine: Clinical Utility, Patient Preferences and…
Therapeutics and Clinical Risk Management · 2023 · Altamura C, Brunelli N, Marcosano M, Alesina A, Fofi L, Vernieri F
Key facts
| Title | Eptinezumab for the Prevention of Migraine: Clinical Utility, Patient Preferences and Selection – A Narrative Review |
|---|---|
| First author | Altamura C, Brunelli N, Marcosano M, Alesina A, Fofi L, Vernieri F |
| Journal | Therapeutics and Clinical Risk Management |
| Published | Nov 23, 2023 |
| DOI | 10.2147/TCRM.S263824 |
| Devices mentioned | K822706 |
| Product codes mentioned | HPX |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1